Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural
myocardial infarction and major cardiac and cerebral events in patients undergoing
percutaneous coronary intervention and who have moderate to high risk for contrast induced
nephropathy.